Sam Wallis, Head of ICSR Case Processing within the Worldwide Patient Safety Operations at Bristol Myers Squibb, will join a Breakthrough 2024 panel discussion on the reality of transitioning Safety/Regulatory systems to the cloud. Here, he provides a glimpse into BMS’s own journey, which he’ll share candidly during the Day 1 debate.
Learn More
Safety can generate immense value for life sciences organizations. To transform safety from a reactive cost center to a proactive…
Learn More
Safety is evolving rapidly. There is a major, emerging opportunity for life sciences organizations that can leverage the latest innovations…
Learn More
What will the next generation of reporting and analytics in pharmacovigilance be? Will it move the needle on business innovation…
Learn More
Concepts once thought to be theoretical are now a reality — from smartphones to space flights. In comparison, the…
Learn More
The Shift to the Cloud Historically, firms relied heavily on on-premises implementations for their enterprise solutions, including safety systems. Reliance…
Learn More
With up to 30-50% annual growth in adverse event cases, how are pharmacovigilance teams managing with today’s constrained budgets,…
Learn More
South Korean Contract Research Organization, LSK, spoke in a webinar with ArisGlobal to address the pressures of modernizing pharmacovigilance…
Learn More
The Future of Drug Safety Intelligence The future of safety intelligence is closer…
Learn More
As part of our commitment to providing the most robust out-of-the-box (OOTB) offering to our safety customers, we recently…
Learn More
Download ArisGlobal’s 2024 Industry Report 
